As coronavirus cases continue to spread around the world, a decade old medicine has reportedly emerged as hope for COVID-19 victims. Some patients infected with the novel coronavirus can develop uncontrolled immune response, leading to potentially life-threatening damage to lung tissue. After seeing promising results in clinical practice, Chinese authorities now recommend Swiss drug maker Roche’s arthritis drug named Actemra to tackle that rampage. Watch this video for more.
As coronavirus cases continue to spread around the world, a decade old medicine has reportedly emerged as hope for COVID-19 victims. Some patients infected with the novel coronavirus can develop uncontrolled immune response, leading to potentially life-threatening damage to lung tissue. After seeing promising results in clinical practice, Chinese authorities now recommend Swiss drug maker Roche’s arthritis drug named Actemra to tackle that rampage. Watch this video for more.
